全文获取类型
收费全文 | 6620篇 |
免费 | 480篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 199篇 |
妇产科学 | 73篇 |
基础医学 | 921篇 |
口腔科学 | 229篇 |
临床医学 | 648篇 |
内科学 | 1682篇 |
皮肤病学 | 140篇 |
神经病学 | 484篇 |
特种医学 | 454篇 |
外科学 | 899篇 |
综合类 | 117篇 |
一般理论 | 1篇 |
预防医学 | 324篇 |
眼科学 | 127篇 |
药学 | 405篇 |
中国医学 | 5篇 |
肿瘤学 | 388篇 |
出版年
2021年 | 60篇 |
2018年 | 81篇 |
2017年 | 78篇 |
2016年 | 78篇 |
2015年 | 79篇 |
2014年 | 121篇 |
2013年 | 204篇 |
2012年 | 190篇 |
2011年 | 204篇 |
2010年 | 131篇 |
2009年 | 136篇 |
2008年 | 226篇 |
2007年 | 217篇 |
2006年 | 209篇 |
2005年 | 189篇 |
2004年 | 159篇 |
2003年 | 169篇 |
2002年 | 155篇 |
2001年 | 207篇 |
2000年 | 193篇 |
1999年 | 182篇 |
1998年 | 141篇 |
1997年 | 141篇 |
1996年 | 143篇 |
1995年 | 106篇 |
1994年 | 104篇 |
1993年 | 108篇 |
1992年 | 175篇 |
1991年 | 169篇 |
1990年 | 171篇 |
1989年 | 202篇 |
1988年 | 178篇 |
1987年 | 155篇 |
1986年 | 154篇 |
1985年 | 126篇 |
1984年 | 108篇 |
1983年 | 72篇 |
1982年 | 71篇 |
1981年 | 82篇 |
1980年 | 85篇 |
1979年 | 85篇 |
1978年 | 83篇 |
1977年 | 71篇 |
1976年 | 78篇 |
1975年 | 69篇 |
1972年 | 67篇 |
1970年 | 65篇 |
1965年 | 67篇 |
1964年 | 56篇 |
1960年 | 70篇 |
排序方式: 共有7140条查询结果,搜索用时 156 毫秒
141.
Subchronic Effects of Dieldrin and Phenobarbital on Hepatic DNA Synthesis in Mice and Rats 总被引:2,自引:1,他引:1
KOLAJA KYLE L.; STEVENSON DONALD E.; JOHNSON JASON T.; WALBORG EARL F. JR.; KLAUNIG JAMES E. 《Toxicological sciences》1996,29(2):219-228
Dieldrin, an organochlorine pesticide, has been shown to behepatocarcinogenic in mice but not rats. Phenobarbital, in contrast,induces hepatic tumors in both mice and rats. Previous studieshave shown that acute dietary exposure of rats or mice to eitherdieldrin or phenobarbital produces several liver changes, includingcentrilobular hypertrophy, induction of hepatic cytochrome P450,and increased liver weight. The present study examined the subchroniceffect of dieldrin (0.1, 1.0, 3.0, 10.0 mg dieldrin/kg diet)and phenobarbital (10, 50, 100, 500 mg phenobarbital/kg diet)on the induction of hepatic DNA synthesis and hepatocyte lethalityin male B6C3F1 mice and male F344 rats. Eight-week-old animalswere treated as above and evaluated for hepatic DNA synthesisafter 7, 14, 21, 28, and 90 days of continual treatment to dieldrinor phenobarbital. Maximal induction of hepatic DNA synthesisin mice was seen at the 14-, 21-, and 28-day sampling times.In rats, no significant increase in hepatic DNA synthesis orhepatocyte lethality was observed at any dose of dieldrin investigated.Phenobarbital produced a significant increase in hepatic DNAsynthesis in both rat and mouse liver following 7 days of treatment.The induction of DNA synthesis in rat liver was transient, withthe labeling index returning to control levels by 14 days oftreatment. In contrast, mice treated with phenobarbital showeda significant increase in hepatic DNA synthesis throughout thetreatment. In both mice and rats, dieldrin and phenobarbitalinduced hepatic DNA synthesis selectively in the centrilobularregion of the hepatic lobule. The lack of an increase in serumenzymes indicative of hepatic damage and the absence of liverhistopathology in mice or rats fed dieldrin or phenobarbitalindicate that the induction of DNA synthesis was not mediatedby a cytolethal, compensatory hyperplastic response, suggestinga mitogenic mechanism. Therefore, the species-specific inductionof hepatic DNA synthesis by either dieldrin or phenobarbitalcorrelated with the previously observed species-specific inductionof hepatic cancer by these two compounds. 相似文献
142.
Understanding a health problem and even having the technological capability to solve it are often not enough to lead to changes in health policy. To help accomplish such policy changes, we propose a five-step approach that involves (1) specifying the disciplines; (2) developing multidisciplinary hypotheses; (3) investigating the hypotheses; (4) developing a policy 'story'; and (5) advocating these solutions to policy makers. We use the example of neonatal hypothermia in Eastern China to illustrate this approach. We found that the approach both better informed policy and better motivated policy change. Using the approach extended our involvement from the hospital to a wider population; in addition our initial solutions expanded from clinical interventions to broader public health approaches that proved to be quite different from our original recommendations. 相似文献
143.
144.
W Günther U Klages M Mayr C Haag N Müller I Hantschk P Streck R Steinberg T Baghai J.P. Banquet P Rondot 《Clinical neurophysiology》1993,23(6)
Twenty-six untreated schizophrenic inpatients and 34 control persons were investigated using 16-channel EEG mapping during resting, manumotor and music perception tasks. Power values of activation tasks were each referenced to a separate, immediately preceding resting condition, using conventional delta, theta, alpha and 2 beta frequency bands. Results in delta and alpha bands, which maximally separated the two groups, are reported only for space reasons. Results indicated a “nonreactivity” (in all frequency bands) on the two activation paradigms in schizophrenic patients as a group. Major gender effects were obtained in normal persons, but not signs of nonreactivity comparable to patients. Subdividing patients exclusively by means of their EEG changes on activation produced meaningful clinical subgroups of “positive/negative” schizophrenics. This latter finding could contribute towards clinical utility of EEG mapping in psychiatry.
Résumé
Vingt-six malades schizophrènes non traités par des médicaments étaient étudiés par l'EEG topographique à 16 voies pendant des tâches psychomotrices et de la perception musicale. Ils étaient comparés à 34 personnes contrôles. Les valeurs de la puissance étaient calculées dans les états de repos et d'activation dans les bandes de fréquences (conventionnelles) delta, theta, alpha et bêta 1 et 2. Seules les bandes delta et alpha, qui séparaient au maximum les deux groupes, sont montrées dans l'article en raison de l'espace. Tandis que les sujets normaux montraient des changements majeurs de l'EEG pendant les deux types de tâches — modifié par le sexe, les malades schizophrènes montraient au contraire des signes de « non-réactivité . L'essai de grouper les malades exclusivement par leurs changements de l'EEG pendant l'activation cérébrale qu'effectuait un groupe était cliniquement significative, en séparant les malades portant des symptomes « positivesde ceux avec des symptomes « négatives . Le résultat final pourrait indiquer une valeur clinique de l'EEG quantifié pour la psychiatrie. 相似文献145.
SLIKKER WILLIAM JR; PAULE MERLE G.; ALI SYED F.; ANDREW C. SCALLET; BAILEY JOHN R. 《Toxicological sciences》1991,17(2):321-334
Chronic Marijuana Smoke Exposure in the Rhesus Monkey I. PlasmaCannabinoid and Blood Carbxyhemoglobin Concentrations and ClinicalChemistry Parameters SLIKKER, W., JR., PAULE, M. G., ALI, S.F., SCALLET, A. C., AND BAILEY, J. R (1991). Fundam. Appl Toxicol17, 321334. This report is the first in a series abouta large multidisciplinary study designed to determine whetherchronic marijuana (MJ) smoke exposure results in residual behavioraland/or neuropathological alterations in the rhesus monkey. Priorto the initiation of a year of chronic MJ smoke exposure, 64periadolescent male rhesus monkeys were trained for 1 year toperform five operant behavioral tasks and then divided, accordingto their performance in these tasks, into four exposure groups(n=1516/group): (1) a high dose (HI) group, exposed 7days/week to the smoke of one standard MJ cigarette; (2) a lowd m (LO) group, exposed on weekend days only to the smoke ofa standard MJ cigarate; (3) an extracted MJ cigarette (EX) group,exposed 7 days/week to the smoke of one ethanol-extracted MJcigarette; and (4) a sham group (SH), exposed 7 days/week tosham exposure conditions. Daily exposures for 1 year were accomplishedusing a mask that covered the subjects' nose and mouth. Averagebody weights (initially 3.7?0.5 kg, mean?SD) and rates of weightgain (approximately 0.1 kg/month) were the same for all groupsthroughout the entire experiment. During the first week of expsure,plasma concentrations of -9-tetrahydrocannabinol and 11-nor-9-carboxy-THCin the HI group were 59?7 (mean?SE) and 5.5?1.5 ng/ml, respectively,45 min after MJ smoke administration and did not change significantlyat similar times after exposure throughout the remainder ofthe year. Whole blood carboxyhemoglobin levels increased toapproximately 13% 1 min after expsure to smoke in either theMJ or the EX groups. Comparison of blood chemistry and hematologyvalues before, during, and after exposure indicated no differencesfor most parameters. During exposure, lymphocytes, alkalinephosphatase and -glutamyl transferase were depressed in theHI group compared to in the SH group. During exposure, aspartateaminotransferase was elevatd for both the HI and EX groups,suggesting a general effect of smoke exposure. Because theseeffects were transient and remained within the range of reportednormal values, these data indicate that long-term, experimentalexperimental exposure to MJ smoke is feasible and does not compromisethe general health of the rhesus monkey. 相似文献
146.
Osteonecrosis of the femoral head in the adult is a progressive condition that, if untreated, usually results in femoral head collapse and secondary osteoarthritis. The experimental application of electrical and electromagnetic fields has been shown to favorably affect a number of biological processes pertinent to osteonecrosis of the femoral head and has led to several clinical trials. The condition has been treated by the application of electrical fields invasively by the surgical implantation of electrodes within the femoral head and noninvasively by capacitative or inductive coupling. This review describes results in osteonecrosis of the femoral head with these therapeutic techniques. Stimulation by means of inductive coupling with pulsed magnetic fields seems to be the most promising technique studied so far, but the optimal signal characteristics and device design are not yet known. 相似文献
147.
Stoodley MA Thompson RC Mitchell RS Marks MP Steinberg GK 《Neurosurgery》2000,46(4):841-51; discussion 851-2
148.
149.
Yves Claustre Danielle De Peretti Philippe Brun Christiane Gueudet Nathalie Allouard Richard Alonso Jo?lle Lourdelet André Oblin Gabrielle Damoiseau Dominique Fran?on Marie-Fran?oise Suaud-Chagny Régis Steinberg Mireille Sevrin Hans Schoemaker Pascal George Philippe Soubrié Bernard Scatton 《Neuropsychopharmacology》2003,28(12):2064-2076
SSR181507 ((3-exo)-8-benzoyl-N-[[(2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl]methyl]-8-azabicyclo[3.2.1]octane-3-methanamine monohydrochloride) is a novel tropanemethanamine benzodioxane derivative that possesses high and selective affinities for D2-like and 5-HT(1A) receptors (K(I)=0.8, 0.2, and 0.2 nM for human D(2), D(3), and 5-HT(1A), respectively). In vivo, SSR181507 inhibited [(3)H]raclopride binding to D(2) receptors in the rat (ID(50)=0.9 and 1 mg/kg, i.p. in limbic system and striatum, respectively). It displayed D(2) antagonist and 5-HT(1A) agonist properties in the same concentration range in vitro (IC(50)=5.3 nM and EC(50)=2.3 nM, respectively, in the GTPgammaS model) and in the same dose range in vivo (ED(50)=1.6 and 0.7 mg/kg, i.p. on striatal DA and 5-HT synthesis, respectively, and 0.03-0.3 mg/kg, i.v. on dorsal raphe nucleus firing rate). It selectively enhanced Fos immunoreactivity in mesocorticolimbic areas as compared to the striatum. This regional selectivity was confirmed in electrophysiological studies where SSR181507, given acutely (0.1-3 mg/kg, i.p.) or chronically (3 mg/kg, i.p., o.d., 22 days), increased or decreased, respectively, the number of spontaneous active DA cells in the ventral tegmental area, but not in the substantia nigra. Moreover, SSR181507 increased both basal and phasic DA efflux (as assessed by microdialysis and electrochemistry) in the medial prefrontal cortex and nucleus accumbens, but not in the striatum. This study shows that the combination of D(2) receptor antagonism and 5-HT(1A) agonism, in the same dose range, confers on SSR181507 a unique neurochemical and electrophysiological profile and suggests the potential of this compound for the treatment of the main dimensions of schizophrenia. 相似文献
150.
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. 总被引:4,自引:0,他引:4
Jennifer A Low Arlene W Berman Seth M Steinberg David N Danforth Marc E Lippman Sandra M Swain 《Journal of clinical oncology》2004,22(20):4067-4074
PURPOSE: To determine long-term event-free (EFS) and overall survival (OS) for patients with stage III breast cancer treated with combined-modality therapy. PATIENTS AND METHODS: Between 1980 and 1988, 107 patients with stage III breast cancer were prospectively enrolled for study at the National Cancer Institute and stratified by whether or not they had features of inflammatory breast cancer (IBC). Patients were treated to best response with cyclophosphamide, doxorubicin, methotrexate, fluorouracil, leucovorin, and hormonal synchronization with conjugated estrogens and tamoxifen. Patients with pathologic complete response received definitive radiotherapy to the breast and axilla, whereas patients with residual disease underwent mastectomy, lymph node dissection, and radiotherapy. All patients underwent six additional cycles of adjuvant chemotherapy. RESULTS: OS and EFS were obtained with a median live patient follow-up time of 16.8 years. The 46 IBC patients had a median OS of 3.8 years and EFS of 2.3 years, compared with 12.2 and 9.0 years, respectively, in stage IIIA breast cancer patients. Fifteen-year OS survival was 20% for IBC versus 50% for stage IIIA patients and 23% for stage IIIB non-IBC. Pathologic response was not associated with improved survival for stage IIIA or IBC patients. Presence of dermal lymphatic invasion did not change the probability of survival in clinical IBC patients. CONCLUSION: Fifteen-year follow-up of stage IIIA and inflammatory breast cancer is rarely reported; IBC patients have a poor long-term outlook. 相似文献